Nuclear DNA Content Selection for High-Producer CHO Cell Lines
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for selecting high-producing cell clones for recombinant protein production are inefficient, as they often rely on correlations between gene copy number and mRNA levels, which do not always predict protein productivity, and lack a reliable early-stage selection method for identifying optimal clones.
Innovation Solution
A method that determines nuclear DNA content to select cell clones with high productivity, correlating high nuclear DNA content with high recombinant protein production, allowing for early-stage selection and reduction of time and costs in identifying optimal clones.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional methods relying on gene copy number and mRNA level correlations are used for clone selection, then selection can be performed without additional measurements, but the prediction of protein productivity is unreliable and selection efficiency is low
Solution Approach 1:
The patent replaces traditional biological correlation methods (gene copy number and mRNA level measurements) with a flow cytometry-based nuclear DNA content measurement system. This substitution enables more accurate prediction of protein productivity by directly measuring nuclear DNA content, which correlates strongly with high producer clones, thereby resolving the contradiction between measurement precision and device complexity.
2Reliability
If all cell clones are evaluated for protein production, then the best-producing clone can be identified, but the process requires significant time and resources
Solution Approach 1:
The patent implements preliminary action by measuring nuclear DNA content using flow cytometry before committing resources to full-scale protein production evaluation. This early-stage screening identifies high-producer clones based on their nuclear DNA content characteristics, allowing researchers to focus subsequent detailed evaluations only on promising candidates, thereby significantly reducing time and resource requirements while maintaining reliable identification of optimal clones.
3Reliability
If comprehensive evaluation of all clones is performed, then the optimum clone can be selected, but costs for reagents, personnel, and facility usage increase
Solution Approach 1:
The patent applies preliminary action by implementing a cost-effective screening step using flow cytometry to measure nuclear DNA content. This preliminary evaluation identifies high-producer clones early in the development process, allowing researchers to avoid costly full-scale production evaluations for clones with low nuclear DNA content. This approach maintains high selection accuracy while significantly reducing overall costs for reagents, personnel, and facility usage.
4Productivity
If early-stage selection methods are implemented, then time and costs are reduced, but the correlation between selection parameter and productivity must be reliably established
Solution Approach 1:
The patent implements feedback by systematically correlating nuclear DNA content measurements with actual protein production data across multiple clones. This feedback mechanism validates the relationship between nuclear DNA content and productivity, ensuring that early-stage selection based on flow cytometry measurements reliably predicts high-producer clones. The feedback loop maintains high measurement precision while enabling efficient early-stage selection.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method effectively identifies high-producing cell clones by correlating nuclear DNA content with protein productivity, reducing the number of clones to evaluate and improving the selection process, thereby enhancing the efficiency and cost-effectiveness of recombinant protein production.
Implementation Method 1
The nuclear DNA content of cell clones was analysed by flow cytometry
Implementation Method 2
The cells were fixed, permeabilized and stained with a nuclear DNA staining solution... The fluorescence intensity in the clones was determined in a flow cytometer
Data Source
AI summary
The present invention relates to a method for selecting for cells or cell lines that produce a recombinant protein/polypeptide in high yields, the method allowing for the selection of high producer cells or cell lines in an early phase of cell line development, the method comprising the step of determining the nuclear DNA content of the cells or cell lines, wherein the level of the nuclear DNA content of the cells or cell lines positively correlates with the capacity of the cells or cell lines to produce the recombinant protein/polypeptide.